These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36891238)

  • 1. Biomarker discovery for tuberculosis using metabolomics.
    Yu Y; Jiang XX; Li JC
    Front Mol Biosci; 2023; 10():1099654. PubMed ID: 36891238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based identification of new serum biomarkers in patients with latent infection pulmonary tuberculosis.
    Li YX; Zheng KD; Duan Y; Liu HJ; Tang YQ; Wu J; Lin DZ; Zhang Z
    Medicine (Baltimore); 2022 Dec; 101(48):e32153. PubMed ID: 36482536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China.
    Xin H; Du Y; Cao X; Wang D; Zhang B; Zhang H; Feng B; He Y; He Y; Quan Z; Liu Z; Yan J; Guan L; Guan X; Shen F; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Dec; 10(6):e0296722. PubMed ID: 36445141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study.
    Xin H; Cao X; Du Y; Yan J; He R; Liu Z; Zhang H; He Y; Zhang B; Wang D; Guan L; Shen F; Feng B; Quan Z; He Y; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0262521. PubMed ID: 35435753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?
    Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N
    Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection.
    Kang YJ; Park H; Park SB; Kim J; Lee J; Kim J; Park S; Lee YS; Kim S
    J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100253. PubMed ID: 34278005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq.
    Xu Y; Tan Y; Zhang X; Cheng M; Hu J; Liu J; Chen X; Zhu J
    J Infect; 2022 Nov; 85(5):534-544. PubMed ID: 36007657
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.